Medtronic has agreed to be the exclusive U.S. distributor of Contego Medical’s portfolio, which includes devices that provide revascularization treatment for carotid and peripheral vascular disease.

Medtronic has agreed to be the exclusive U.S. distributor of Contego Medical’s portfolio, which includes devices that provide revascularization treatment for carotid and peripheral vascular disease.

Medtronic (NYSE: MDT) + announced today that it entered into an exclusive U.S. distribution agreement with Contego Medical. Under the agreement, Medtronic serves as the sole U.S. distributor for ...

January 13, 2025—Medtronic announced it has entered into an exclusive United States distribution agreement with Raleigh, North Carolina-based Contego Medical. The company stated that under the ...

Background The optimal duration for dual antiplatelet therapy (DAPT) after stent-assisted coiling (SAC) of intracranial aneurysms is unclear. Longer-term therapy may reduce thrombotic complications ...

and ICU thrombectomy Medtronic Mo.Ma Ultra Proximal Cerebral Protection Device Proximal protection Proximal Indicated as an EPS to contain and remove embolic material (thrombus/debris) while ...

Shares of Medtronic are benefiting from an improved earnings growth outlook. The company is capturing strong demand for its new lineup of high-tech medical devices. The stock trades at just 16 ...

Shares of Medtronic (NYSE: MDT) are off to a fantastic start in 2025, already rising by 13% year to date. The medical devices giant had some weakness in recent years amid disappointing trends from ...

At the 43rd annual J.P. Morgan Healthcare Conference on Monday, Medtronic CEO Geoff Martha mixed in some breaking news with his usual pitch to investors. Just hours earlier, the Centers for ...

Analyst Travis Steed of Bank of America Securities maintained a Buy rating on Medtronic (MDT – Research Report), retaining the price target of $100.00. Discover outperforming stocks and invest ...